Duchenne Muscular Dystrophy Ongoing Global Clinical Trials Analysis and Outlook
Duchenne Muscular Dystrophy ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Duchenne Muscular Dystrophy disease clinical trials. The research work analyzes the ongoing Duchenne Muscular Dystrophy clinical trial trends across countries and companies.
The report focuses on drugs and therapies being evaluated for Duchenne Muscular Dystrophy treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.
Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Duchenne Muscular Dystrophy clinical trials.
Scope of the Report-
The report focuses on drugs and therapies being evaluated for Duchenne Muscular Dystrophy treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.
Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Duchenne Muscular Dystrophy clinical trials.
Scope of the Report-
- Ongoing Duchenne Muscular Dystrophy clinical trials across regions
- Trial information by Phase and Subjects recruited
- Trial information by status, type, sponsor type
- Drugs used for treatment of Duchenne Muscular Dystrophy
- Both observational and interventional trials analyzed
- Leading companies and universities participating in Duchenne Muscular Dystrophy clinical trials
- Track competition and design competitive advantages
- Identify right partners to associate with for further research
- Evaluate potential opportunities available in further clinical trials of the disease
- Formulate business development strategies through success rates of clinical trials
- Identify quick markets for recruiting subjects based on trials count by each market
1 TABLE OF CONTENTS
1.1 List of Figures
1.2 List of Tables
2 KEY FINDINGS, 2018
2.1 Snapshot
2.2 Overview of Duchenne Muscular Dystrophy Trials
3 CLINICAL TRIALS TRENDS TO 2022
3.1 Ongoing Duchenne Muscular Dystrophy Trials by Phase
3.2 Ongoing Duchenne Muscular Dystrophy Trials by Type
3.3 Ongoing Duchenne Muscular Dystrophy Trials by Recruitment Status
4 COUNTRY LEVEL ANALYSIS
4.1 Region wise Ongoing Duchenne Muscular Dystrophy Trials
4.2 Top 10 Countries conducting Duchenne Muscular Dystrophy Trials
4.3 Trials in Emerging and Developing Economies
5 COMPANY LEVEL ANALYSIS
5.1 Ongoing Duchenne Muscular Dystrophy Trials by Sponsor Type
5.2 Duchenne Muscular Dystrophy Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors
6 ENROLMENT TRENDS TO 2022
6.1 Subjects Recruited for Duchenne Muscular Dystrophy Trials by year
6.2 Subjects Recruited for Duchenne Muscular Dystrophy Trials by Phase
6.3 Subjects Recruited for Duchenne Muscular Dystrophy Trials by Trial Type
6.4 Subjects Recruited for Duchenne Muscular Dystrophy Trials by Recruitment Status
7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS
7.1 Ongoing Duchenne Muscular Dystrophy Trials- Phase
7.2 Ongoing Duchenne Muscular Dystrophy Trials- Phase
7.3 Ongoing Duchenne Muscular Dystrophy Trials- Phase
7.4 Ongoing Duchenne Muscular Dystrophy Trials- Phase
8 APPENDIX
8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology
1.1 List of Figures
1.2 List of Tables
2 KEY FINDINGS, 2018
2.1 Snapshot
2.2 Overview of Duchenne Muscular Dystrophy Trials
3 CLINICAL TRIALS TRENDS TO 2022
3.1 Ongoing Duchenne Muscular Dystrophy Trials by Phase
3.2 Ongoing Duchenne Muscular Dystrophy Trials by Type
3.3 Ongoing Duchenne Muscular Dystrophy Trials by Recruitment Status
4 COUNTRY LEVEL ANALYSIS
4.1 Region wise Ongoing Duchenne Muscular Dystrophy Trials
4.2 Top 10 Countries conducting Duchenne Muscular Dystrophy Trials
4.3 Trials in Emerging and Developing Economies
5 COMPANY LEVEL ANALYSIS
5.1 Ongoing Duchenne Muscular Dystrophy Trials by Sponsor Type
5.2 Duchenne Muscular Dystrophy Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors
6 ENROLMENT TRENDS TO 2022
6.1 Subjects Recruited for Duchenne Muscular Dystrophy Trials by year
6.2 Subjects Recruited for Duchenne Muscular Dystrophy Trials by Phase
6.3 Subjects Recruited for Duchenne Muscular Dystrophy Trials by Trial Type
6.4 Subjects Recruited for Duchenne Muscular Dystrophy Trials by Recruitment Status
7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS
7.1 Ongoing Duchenne Muscular Dystrophy Trials- Phase
7.2 Ongoing Duchenne Muscular Dystrophy Trials- Phase
7.3 Ongoing Duchenne Muscular Dystrophy Trials- Phase
7.4 Ongoing Duchenne Muscular Dystrophy Trials- Phase
8 APPENDIX
8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology
LIST OF FIGURES
Figure 1: Duchenne Muscular Dystrophy- Clinical Trials by Country
Figure 2: Duchenne Muscular Dystrophy- Clinical Trials by Phase of Development, 2018
Figure 3: Duchenne Muscular Dystrophy- Clinical Trials by Status, 2018
Figure 4: Duchenne Muscular Dystrophy- Clinical Trials by Type, 2018
Figure 5: Duchenne Muscular Dystrophy- Clinical Trials Split by Region, 2000-2018
Figure 6: Duchenne Muscular Dystrophy- Clinical Trials by Type of Economy, 2018
Figure 7: Duchenne Muscular Dystrophy- Enrolment by Phase, 2018
Figure 8: Duchenne Muscular Dystrophy- Enrolment by Trial Type, 2018
Figure 9: Duchenne Muscular Dystrophy- Enrolment by Recruitment Status, 2018
Figure 10: Duchenne Muscular Dystrophy- Clinical Trials by Sponsor Type, 2018
Figure 11: Duchenne Muscular Dystrophy- Enrolment by Type of Sponsors
Figure 12: Duchenne Muscular Dystrophy- Enrolment by Leading Sponsors
Figure 1: Duchenne Muscular Dystrophy- Clinical Trials by Country
Figure 2: Duchenne Muscular Dystrophy- Clinical Trials by Phase of Development, 2018
Figure 3: Duchenne Muscular Dystrophy- Clinical Trials by Status, 2018
Figure 4: Duchenne Muscular Dystrophy- Clinical Trials by Type, 2018
Figure 5: Duchenne Muscular Dystrophy- Clinical Trials Split by Region, 2000-2018
Figure 6: Duchenne Muscular Dystrophy- Clinical Trials by Type of Economy, 2018
Figure 7: Duchenne Muscular Dystrophy- Enrolment by Phase, 2018
Figure 8: Duchenne Muscular Dystrophy- Enrolment by Trial Type, 2018
Figure 9: Duchenne Muscular Dystrophy- Enrolment by Recruitment Status, 2018
Figure 10: Duchenne Muscular Dystrophy- Clinical Trials by Sponsor Type, 2018
Figure 11: Duchenne Muscular Dystrophy- Enrolment by Type of Sponsors
Figure 12: Duchenne Muscular Dystrophy- Enrolment by Leading Sponsors
LIST OF TABLES
Table 1: Duchenne Muscular Dystrophy- Clinical Trials by Sponsor Type, 2018
Table 2: Duchenne Muscular Dystrophy- Clinical Trials by Economy Type, 2018
Table 3: Duchenne Muscular Dystrophy- Clinical Trials by Region, 2018
Table 4: Duchenne Muscular Dystrophy- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Duchenne Muscular Dystrophy- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Duchenne Muscular Dystrophy- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Duchenne Muscular Dystrophy- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Duchenne Muscular Dystrophy- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Duchenne Muscular Dystrophy- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 1: Duchenne Muscular Dystrophy- Clinical Trials by Sponsor Type, 2018
Table 2: Duchenne Muscular Dystrophy- Clinical Trials by Economy Type, 2018
Table 3: Duchenne Muscular Dystrophy- Clinical Trials by Region, 2018
Table 4: Duchenne Muscular Dystrophy- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Duchenne Muscular Dystrophy- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Duchenne Muscular Dystrophy- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Duchenne Muscular Dystrophy- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Duchenne Muscular Dystrophy- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Duchenne Muscular Dystrophy- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
